Physician profile
Matthew M Ryan
NPI 1003951500
$11,445.96
in general payments reported to CMS, 2019-2025
49 companies · $3,306 in 2025
The $3,306 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2020: $792 · 2021: $1,546 · 2022: $463 · 2023: $1,265 · 2024: $2,927 · 2025: $3,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,498.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,591.32 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Lundbeck LLC | $724.53 | 2019-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $685.01 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Sk Life Science, INC. | $622.95 | 2020-2025 | |
| Ucb, INC. | $505.08 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Neurocrine Biosciences, INC. | $470.76 | 2020-2025 | Ingrezza, Ongentys |
| Livanova USA, INC. | $430.35 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Pfizer INC. | $424.60 | 2023-2025 | |
| Eisai INC. | $402.92 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $377.78 | 2019-2025 | |
| Biogen, INC. | $363.95 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Argenx US, INC. | $363.87 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Allergan, INC. | $295.50 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $249.32 | 2019 | |
| Lilly USA, LLC | $246.03 | 2019-2025 | Emgality, Reyvow, Kisunla |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.